Watch for Shares of Bristol-Myers Squibb (BMY) to Approach Support at $30.45 Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Bristol-Myers Squibb (NYSE:BMY) has potential upside of 6.8% ... |
